Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mauri

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2018
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE studyM Thomas, S Ponce-Aix, A Navarro, et al.
Panminerva Medica|April 1, 1980
Hodgkin's disease and non-Hodgkin's lymphomasC Mauri, V Silingardi, S Perugini, et al.
Breast (Edinburgh, Scotland)|January 7, 2011
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in ItalyS Bianchi, S Caini, G Renne, et al.
Clinical and Experimental Immunology|May 12, 2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortiumB Rup, M Pallardy, D Sikkema, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2018
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE studyM Thomas, S Ponce-Aix, A Navarro, et al.
Panminerva Medica|April 1, 1980
Hodgkin's disease and non-Hodgkin's lymphomasC Mauri, V Silingardi, S Perugini, et al.
Breast (Edinburgh, Scotland)|January 7, 2011
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in ItalyS Bianchi, S Caini, G Renne, et al.
Clinical and Experimental Immunology|May 12, 2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortiumB Rup, M Pallardy, D Sikkema, et al.
Pageof 14